z-logo
open-access-imgOpen Access
Natural Products as A Promising Therapy for SARS COV-2; An Overview
Author(s) -
Noor S Jaafar,
Iman Sabah Jaafar
Publication year - 2021
Publication title -
al-maǧallaẗ al-’irāqiyyaẗ li-l-’ulūm al-ṣaydalāniyyaẗ/iraqi journal of pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.122
H-Index - 1
eISSN - 2521-3512
pISSN - 1683-3597
DOI - 10.31351/vol30iss1pp29-40
Subject(s) - pharmacology , glycyrrhizin , chemistry , curcumin , myricetin , protease , biochemistry , theaflavin , luteolin , quercetin , traditional medicine , biology , polyphenol , enzyme , medicine , kaempferol , antioxidant
Recently emerging pandemic SARS CoV-2 conquered our world since December 2019. Continuous efforts have been done to find out effective immunization and precise treatment stetratigies A way from therapeutic options that were tried in SARS CoV-2, an increased attention is directed to predict natural products and mainly phytochemicals as collaborative measures for this crisis. In this review, most of the mentioned compounds specially flavonoids (biacalin, hesperidin, quercetin, luteolin,, and phenolic (resveratrol, curcumin, and theaflavin) exert their effect through interfering with the action of one or more of this proteins (spike protein, papain like protease, 3 chymotrypsin like cysteine protease, and RNA dependent RNA  polymerase) that are involved in viral life cycle beside the anti-inflammatory effect of these compounds. The triterpenoids (celastrol, escin and glycyrrhizin) and the alkaloids (lycorine and cepharanthine) mediated their effect mainly through anti-inflammatory activity.  Glycyrrhetinic acid (glycyrrhizin metabolite) dawn regulates ACE  2, and reduces protease expression, thus reduce viral entry.  This review may be representing an initial step in long path for designing the successful and effective treatment or vaccine for this pandemic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here